Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
Sell
50
DRUG Quote, Financials, Valuation and Earnings
Last price:
$30.10
Seasonality move
:
10.59%
Day range:
$29.75 - $31.75
52-week range:
$0.93 - $79.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.26x
Volume:
27.5K
Avg. volume:
29.8K
1-year change:
2739.62%
Market cap:
$212M
Revenue:
--
EPS (TTM):
-$0.18
Earnings Data
Next earnings date for DRUG
May 15
2025
Most recent earnings per share
$0.01
Beat by $0.35
(Feb 13/2025)
Consensus Estimate
-$0.35
(Feb 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRUG Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.49 | -- |
| 05/15/2025 | Q1 | -- | -- | -- | -$0.33 | -- |
| 02/13/2025 | Q4 | -- | -- | $0.01 | -$0.35 | $0.35 |
| 09/30/2024 | Q3 | -- | -- | -$0.12 | -$0.43 | $0.30 |
| 06/30/2024 | Q2 | -- | -- | $0.04 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.30 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.29 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.40 | -- | -- |
| 02/14/2023 | Q4 | -- | -- | -$0.48 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.77 | -- | -- |
| 08/30/2022 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.50 | -- | -- |
| 02/14/2022 | Q4 | -- | -- | -$1.63 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.97 | -- | -- |
| 08/30/2021 | Q2 | -- | -- | -$1.26 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.91 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.41 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.02 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.02 | -- | -- |
Bright Minds Biosciences Earnings Questions
-
How Much did Bright Minds Biosciences Generate in Revenue Last Quarter?
Bright Minds Biosciences reported -- worth of top line sales in its most recent quarter.
-
Did Bright Minds Biosciences Beat Earnings Last Quarter?
Bright Minds Biosciences announced earnings per share of $0.01 which represents a beat of analyst forecast a -$0.35 per share.
-
Is Bright Minds Biosciences Profitable?
Bright Minds Biosciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Bright Minds Biosciences EPS Next Year?
Bright Minds Biosciences's earnings are forecast to decrease from -$0.48 per share to -$0.78 per share next year representing a decrease of -196.33%.
-
When is Bright Minds Biosciences's Earnings Date?
Bright Minds Biosciences's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 16.22% over the past day.
Buy
92
TPB alert for May 8
Turning Point Brands [TPB] is down 6.32% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 2.21% over the past day.
